Pharmaceutical Information |
Drug Name |
Benzylpenicilloyl polylysine |
Drug ID |
BADD_D00251 |
Description |
Benzylpenicilloyl polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects. |
Indications and Usage |
For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G). |
Marketing Status |
approved |
ATC Code |
Not Available |
DrugBank ID |
DB00895
|
KEGG ID |
D03095
|
MeSH ID |
C509029
|
PubChem ID |
45266800
|
TTD Drug ID |
D0J7TM
|
NDC Product Code |
49471-001 |
UNII |
76479814OY
|
Synonyms |
benzylpenicilloyl G polylysine | BPO-oligolysine | benzylpenicilloyl-G-polylysine |
|
Chemical Information |
Molecular Formula |
C28H46N6O8S |
CAS Registry Number |
31855-75-1 |
SMILES |
CC1(C(NC(S1)C(C(=O)NCCCCC(C(=O)O)N)NC(=O)CC2=CC=CC=C2)C(=O)O)C.C(CCN)CC(C(=O)O)N |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Anaphylactic reaction | 10.01.07.001; 24.06.03.006 | - | - | | Angioedema | 22.04.02.008; 23.04.01.001; 10.01.05.009 | - | - | Not Available | Dyspnoea | 02.11.05.003; 22.02.01.004 | - | - | | Erythema | 23.03.06.001 | - | - | Not Available | Hypotension | 24.06.03.002 | - | - | | Pruritus | 23.03.12.001 | - | - | | Urticaria | 23.04.02.001; 10.01.06.001 | - | - | |
|
The 1th Page
1
Total 1 Pages
|
|